• In a study of kidney transplant recipients, those with higher adherence to the Mediterranean diet were less likely to experience kidney function loss.
Four University of Chicago Medicine patients who received rare triple-organ transplants are encouraging people to register as organ and tissue donors, hoping to raise awareness about giving the gift of life during a holiday season focused on giving.
Erika Hosey, a cardiovascular technician at University Hospitals Ahuja Medical Center, ended the year by giving a life-changing gift to a patient in need. While performing a routine cardiac stress test, she drummed up a conversation. She learned that her patient, Denise Butvin, had kidney disease and needed transplant surgery. “Erika just blurted out…I’ll give you my kidney,” said Butvin. “I was in shock. I couldn’t believe this was real.” While Butvin is a positive person, she has been through an emotional rollercoaster of ups and downs and on waitlists in Ohio and Pennsylvania for five years. Her family and friends were not an organ match. Both her sister and father were on dialysis for many years and passed away from kidney disease, so she knew how pressing this transplant surgery was. Hosey started the process the next day, and after a few weeks of testing turned out to be a perfect donor match. “To be a kidney donor match for someone is really a shot in the dark,” she
While the donation and transfusion of blood are very common, and relatively simple as far as medical procedures go, the path from donor to recipient is more complex than most people may realize.
The US Department of Health and Human Services (HHS) today took bold steps in two proposed rules to increase the availability of organs for the 113,000 Americans waiting for a lifesaving organ transplant – 20 of whom die each day – and to strengthen support for Americans who choose to be living donors. Both proposed rules advance policy changes the American Society of Nephrology has long been advocating for and is strongly supportive of.
A new analysis shows that a donor stem cell transplant following treatment with an immune checkpoint inhibitor is generally safe and produces good outcomes for patients with Hodgkin lymphoma.
For patients with high-risk myeloid cancers undergoing a donor stem cell transplant, adding the targeted drug venetoclax to a reduced-intensity drug regimen prior to transplant is safe and does not impair the ability of the donor cells to take root in recipients’ bodies, a study led by Dana-Farber Cancer Institute researchers suggests.
Cleveland Clinic researchers have found that using lungs from donors who are considered high risk for certain infectious diseases compared to standard risk donors results in similar one-year survival for recipients. In addition, researchers saw no difference in rejection or graft (donor lung) survival after one year in patients receiving lungs from increased-risk donors. The study was published recently in the Journal of Thoracic and Cardiovascular Surgery.
Rutgers Cancer Institute of New Jersey investigators compared outcomes for allogeneic stem cell transplant patients when post-transplant cyclophosphamide (PCy) was added as part of standard treatment than if standard treatment was given alone. Results showed an increase in the number of patients who were free of disease and off immunosuppression at one-year in the PCy cohort.
HCVguidelines.org — a website developed by the American Association for the Study of Liver Diseases and the Infectious Diseases Society of America to provide up-to-date guidance on the management of hepatitis C — was recently revised to reflect important developments in the identification and management of chronic hepatitis C (HCV)
New research led by a team from the University of Chicago Medicine suggests treatment guidelines for newly diagnosed prostate cancer patients who are waiting for an organ transplant or who are post-transplant.
Dana-Farber Cancer Institute researchers will present more than 40 research studies at the 61st American Society of Hematology (ASH) Annual Meeting on December 7-10 in Orlando, Fla.
Mayo Clinic's Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) and Children's of Alabama announce their collaboration within a consortium to provide solutions for patients with hypoplastic left heart syndrome, a rare and complex form of congenital heart disease in which the left side of the heart is severely underdeveloped.
The 61st American Society of Hematology Annual Meeting and Exposition will take place Dec. 7–10 in Orlando, Florida
A recent study published in Muscle & Nerve appears to show that needle electromyography can play a major role in reinnervation in face transplantation.
Juan Cueto did not feel sick, but he was losing weight rapidly and was devastated with the knowledge that he had two life threatening diseases, cancer and a liver disease.
Researchers report that among patients with obesity, robotic kidney transplants produce survival outcomes comparable to those seen among nonobese patients. The study includes data collected over 10 years from more than 230 robotic-assisted kidney transplants in patients with obesity.
Vanderbilt University Medical Center is launching a living liver donor transplant program, significantly increasing the number of available organs for life-saving transplants
University of Maryland School of Medicine researchers found that lung transplant recipients with early signs of organ rejection could increase their chance of survival and improve lung function by inhaling a liposomal form of the immunosuppression drug cyclosporine through an investigational nebulizer.
Researchers at University of California San Diego School of Medicine, as well as a diverse team of cardiologists and physicists, developed a machine learning algorithm to predict the life expectancy in heart failure patients.
Analysis of more than 29,000 adults listed on the national heart transplant registry from 2006 to 2015 shows how rules that give hospitals discretion in determining who gets a transplant result in large discrepancies in how sick patients are when they receive heart transplants at hospitals across the United States.
Dr. Eugene Chang was 25, recently engaged and halfway through a physical medicine and rehabilitation residency in Vancouver when he started feeling sick. Fatigue, dizziness and nausea took over his normally active lifestyle. Suddenly his bike to work was not so easy.
The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented at ASN Kidney Week 2019 November 5–November 10 at the Walter E. Washington Convention Center in Washington, DC.
Data from a new study presented this week at The Liver Meeting® – held by the American Association for the Study of Liver Diseases – found that combination therapy with direct-acting antivirals (DAAs) and ezetimibe
• Extending Medicare coverage of anti-rejection medications beyond 36 months after a kidney transplant would lead to lower costs and an improvement in patients’ quality of life. • Results from the study will be presented at ASN Kidney Week 2019 November 5–November 10 at the Walter E. Washington Convention Center in Washington, DC.
Using U.S. transplant registry data, clinical researchers at the University of Pittsburgh found that kidney transplants between identical twins have high success rates, but also surprisingly high rates of immunosuppressant use.
Lurie Children's Hospital in Chicago adds another fetal surgeon to complement its robust program.
The National Comprehensive Cancer Network (NCCN) published new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Hematopoietic Cell Transplantation, (aka stem cell transplant or bone marrow transplant), with step-by-step information on best practices for this blood cancer treatment
Cleveland Clinic has successfully performed the Midwest’s first purely laparoscopic living donor surgery for liver transplantation in an adult recipient. The advanced procedure is available at only a few hospitals worldwide, and Cleveland Clinic is the second U.S. academic medical center to offer this approach for living donor liver transplantation.
As part of an effort to improve long-term outcomes, a national team led by a researcher at Penn Medicine has launched a study--funded by a $9.8 million grant from the NIH--to better understand clinical and biological processes that occur after transplant and lead to the development of these complications.
• In 2010-2016, many U.S. transplant centers commonly accepted deceased donor kidneys with less desirable characteristics. • The use of these organs varied widely across transplant centers, however, and differences were not fully explained by the size of waitlists or the availability of donor organs.
A new study from the University of Michigan suggests that a policy shift to opt-in as an organ donor -- so called "presumed consent" -- would marginally reduce the waiting list for organ transplant.
• The proportion of preemptive transplants—when a patient receives a kidney transplant before starting dialysis—increased after implementation of the 2014 Kidney Allocation System from 9.0% to 9.8% of all kidney transplants. • Increases in preemptive transplantation were not shared equally among all patient groups, however, and disparities were actually exacerbated for Black and Hispanic patients and for patients on Medicare.
Rush University Medical Center was the top ranked large academic medical center in the country in the 2019 Vizient Quality and Accountability Study, which many experts consider to be the most accurate gauge of the quality of care a hospital delivers because it is entirely based on data from all patients, not reputation.
In experiments in mice, Johns Hopkins Medicine researchers say they have developed a way to successfully transplant certain protective brain cells without the need for lifelong anti-rejection drugs.
A recent analysis reveals that kidneys from donors infected with hepatitis C virus (HCV) are now routinely used in transplants at many U.S. centers, and they are functioning well one year after transplantation.
Kidneys from donors who were infected with the Hepatitis C virus (HCV) function just as well as uninfected kidneys throughout the first year following transplantation, according to a new Penn Medicine study.
UAB has successfully completed more than 14,000 transplants since doctors performed Alabama’s first kidney transplant in 1968.
UNM Cancer Center’s Bone Marrow Transplant program is the first in the state to achieve FACT accreditation, enabling many more New Mexicans with blood disorders to stay home
Baylor University Medical Center at Dallas, a part of Baylor Scott & White Health, today announces that a third family has welcomed a baby after the mother participated in a landmark uterus transplant clinical trial.
Mayo Clinic在佛罗里达州新建的探索与创新楼于8月22日（周四）正式开放。在此运用的先进技术将增加可供移植的肺器官数量。另外，这栋占地75,000平方英尺的大楼还会配设创新型生命科学孵化器，让企业家能够利用各项资源将医疗解决方案推向市场。
On the day he was born, Patrick Davey saved a woman's life. His parents donated his umbilical cord blood, which was used in a stem cell transplant that saved the life of cancer patient Holly Becker.
Das neue Entdeckungs- und Innovationsgebäude der Mayo Clinic in Florida eröffnete am Donnerstag, dem 22. August. Hier wird durch wegweisende Technologie die Anzahl der für die Transplantation verfügbaren Lungen erhöht. In dem rund 7000 Quadratmeter großen Gebäude wird sich auch ein innovativer Life Sciences Incubator befinden, der Unternehmer mit Ressourcen verbindet, um medizinische Lösungen auf den Markt zu bringen.
Le nouveau Discovery and Innovation Building de la Mayo Clinic en Floride, un bâtiment dédié à la recherche et à l’innovation, a ouvert ses portes le jeudi 22 août. Dans cet endroit, une technologie novatrice augmentera le nombre de poumons disponibles pour les transplantations.
Most patients who died or were removed from the kidney transplant waitlist before getting a transplant received multiple offers for a donor kidney.
El jueves 22 de agosto, se inauguró en Mayo Clinic de Florida el nuevo edificio “Descubrimientos e Innovación”, donde mediante tecnología pionera se incrementará la cantidad de pulmones disponibles para trasplante.
Median survival after lung transplant is less than six years. To see what might help lung transplant recipients live longer, University of Maryland School of Medicine researchers analyzed US lung transplant data, focused on immunosuppression regimes, and found a drug combination that appears to significantly extend patient survival.
For the first time in Southern California, surgeons at UC San Diego Health have transplanted the kidney of a deceased donor with HIV into a recipient with a pre-existing HIV infection. The procedure is part of an unprecedented multi-site national clinical trial.
French organ transplant centers are far more likely to accept “lower-rated” kidneys, like those from older organ donors, than centers in the United States, according to a study published today in JAMA Internal Medicine.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right